Skip to main content

Advertisement

SpringerLink
Log in

Decompensated Liver Disease in a Patient with Neurocysticercosis

  • UNM Clinical Case Conferences
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Chaudhary V, Bano S, Kumar P, Narula MK, et al. Hepatic cysticercosis: a rare entity. Abdom Imaging. 2012;39:1182–1185.

    Article  Google Scholar 

  2. Elbaz T, Esmat G. Hepatic and intestinal schistosomiasis: a review. J Adv Res. 2013;4:445–452.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Coash M, Forouhar F, Wu CH, Wu GY. Granulomatous liver diseases: a review. J Formos Med Assoc. 2012;111:3–13.

    Article  PubMed  Google Scholar 

  4. Gutiérrez-Grobe Y, Bahena-Gonzalez JA, Herrera-Gomar M, Mendoza-Diaz P, et al. Acute liver failure associated with levetiracetam and lacosamide combination treatment for unspecified epileptic disorder. Case Rep Emerg Med. 2013;63:4174.

    Google Scholar 

  5. Azar NJ, Aune P. Acute pancreatitis and elevated liver transaminases after rapid titration of oral levetiracetam. J Clin Neurosci. 2012;21:1053–1054.

    Article  Google Scholar 

  6. Sethi NK, Sethi PK, Torgovnick J, Arsura E, et al. Asymptomatic elevation of liver enzymes due to levetiracetam: a case report. Drug Metab Drug Interact. 2011;28:123–124.

    Google Scholar 

  7. Skopp G, Schmitt HP, Pedal I. Fulminant liver failure in a patient on carbamazepine and levetiracetam treatment associated with status epilepticus. Arch Kriminol. 2003;217:161–175.

    Google Scholar 

  8. Tan TC, de Boer BW, Mitchell A, Delriviere L, et al. Levetiracetam as a possible cause of fulminant liver failure. Neurology. 2006;71:685–686.

    Article  Google Scholar 

  9. Rodriguez-Castro KI, Hevia-Urrutia FJ, Sturniolo GC. Wilson’s disease: a review of what we have learned. World J Hepatol. 2015;7:2859–2870.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Lorincz MT. Neurologic Wilson’s disease. Ann N Y Acad Sci. 2010;1184:173–187.

    Article  CAS  PubMed  Google Scholar 

  11. Weiss KH. Wilson disease. In: Pagon RA, Adam MP, Bird TD et al., eds. GeneReviews [Internet]. Seattle, WA: University of Washington; 1993–2017. http://www.ncbi.nlm.nih.gov/books/NBK1512/.

  12. Prashanth LK, Sinha S, Taly AB, Mahadevan A, et al. Spectrum of epilepsy in Wilson’s disease with electroencephalographic, MR imaging and pathological correlates. J Neurol Sci. 2008;291:44–51.

    Article  Google Scholar 

  13. Lerner A, Shiroishi MS, Zee CS, Law M, et al. Imaging of neurocysticercosis. Neuroimaging Clin N Am. 2012;22:659–676.

    Article  PubMed  Google Scholar 

  14. European Association for the Study of the Liver. EASL clinical practice guidelines: Wilson’s disease. J Hepatol. 2012;56:671–685.

    Article  Google Scholar 

  15. Roberts EA, Schilsky ML. American Association for Study of Liver Diseases. Diagnosis and treatment of Wilson disease: an update. Hepatol. 2008;47:2089–2111.

    Article  CAS  Google Scholar 

  16. Merle U, Schaefer M, Ferenci P, Stremmel W. Clinical presentation, diagnosis and long-term outcome of Wilson’s disease: a cohort study. Gut. 2005;56:115–120.

    Article  Google Scholar 

  17. Arikan C, Ozgenc F, Akman SA, Kilicet M, et al. Impact of liver transplantation on renal function of patients with congenital hepatic fibrosis associated with autosomal recessive polycystic kidney disease. Pediatr Transpl. 2002;8:558–560.

    Article  Google Scholar 

  18. Srivastava A. Progressive familial intrahepatic cholestasis. J Clin Exp Hepatol. 2014;4:25–36.

    Article  PubMed  Google Scholar 

  19. Kimura N, Kubo N, Narumi S, Toyoki Y, et al. Liver transplantation versus conservative treatment for adult-onset type II citrullinemia: our experience and a review of the literature. Transpl Proc. 2013;45:3432–3437.

    Article  CAS  Google Scholar 

  20. Magoulas PL, El-Hattab AW. Glycogen storage disease type IV. In: Pagon R, Adam MP, Bird TD et al. eds. GeneReviews [Internet]. Seattle, WA: University of Washington; 1993–2017. https://www.ncbi.nlm.nih.gov/books/NBK115333/.

  21. Gunay-Aygun M, Gahl WA, Heller T. Congenital hepatic fibrosis overview. In: Pagon RA, Adam MP, Bird TD, et al. eds. GeneReviews [Internet].Seattle, WA: University of Washington; 1993–2017. https://www.ncbi.nlm.nih.gov/books/NBK2701/.

  22. Bacon BR, Adams PC, Kowdley KV, Powell LW, et al. Diagnosis and management of hemochromatosis: 2011 Practice Guidelines by the American Association for the Study of Liver Diseases. Hepatology. 2011;54:328–343.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Teckman JH, Lindblad D. Alpha-1-antitrypsin deficiency: diagnosis, pathophysiology, and management. Curr Gastroenterol Rep. 2006;8:14–20.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM, USA

    Sarah Safadi & Barakat A. Altamimi

  2. Division of Gastroenterology and Hepatology, University of New Mexico School of Medicine, 1 University of New Mexico, MSC10-5550, Albuquerque, NM, 87131, USA

    Aly M. Mohamed, Robert G. Strickland & Denis M. McCarthy

Authors
  1. Sarah Safadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aly M. Mohamed
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Barakat A. Altamimi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Robert G. Strickland
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Denis M. McCarthy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aly M. Mohamed.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Safadi, S., Mohamed, A.M., Altamimi, B.A. et al. Decompensated Liver Disease in a Patient with Neurocysticercosis. Dig Dis Sci 62, 1443–1447 (2017). https://doi.org/10.1007/s10620-017-4590-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-017-4590-2

Keywords

Search

Navigation